New Zealand markets open in 9 hours 11 minutes

Shanghai Medicilon Inc. (688202.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
31.81-1.15 (-3.49%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.44B
Enterprise value 3.96B
Trailing P/E 38.48
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.68
Price/book (mrq)1.81
Enterprise value/revenue 3.38
Enterprise value/EBITDA 33.56

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-64.83%
S&P500 52-week change 323.49%
52-week high 398.89
52-week low 331.39
50-day moving average 337.84
200-day moving average 359.06

Share statistics

Avg vol (3-month) 33.77M
Avg vol (10-day) 31.86M
Shares outstanding 5134.67M
Implied shares outstanding 6134.67M
Float 883.5M
% held by insiders 147.42%
% held by institutions 18.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.39
Forward annual dividend yield 41.18%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 427.49%
Dividend date 3N/A
Ex-dividend date 402 Jun 2023
Last split factor 21.4:1
Last split date 302 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -14.68%
Operating margin (ttm)-20.75%

Management effectiveness

Return on assets (ttm)-5.76%
Return on equity (ttm)-8.28%

Income statement

Revenue (ttm)1.17B
Revenue per share (ttm)8.96
Quarterly revenue growth (yoy)-42.50%
Gross profit (ttm)N/A
EBITDA -168.26M
Net income avi to common (ttm)-172.33M
Diluted EPS (ttm)-1.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)813.35M
Total cash per share (mrq)6.04
Total debt (mrq)338.73M
Total debt/equity (mrq)13.78%
Current ratio (mrq)2.86
Book value per share (mrq)18.25

Cash flow statement

Operating cash flow (ttm)-7.79M
Levered free cash flow (ttm)-137.1M